This unexpected trend was also seen within the TCGA breast cancer data set, with the DC2 signature correlating more strongly with increased survival than the DC1 signature or the immune response score (Supplemental Figure 1A; supplemental material available online with this article; https://doi.org/10.1172/jci.insight.145885DS1). This evidence concerns the gene ZDHHC4 and breast carcinoma.